If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
47.75    -0.05 (-0.10%)
Bid:
47.80
Ask:
48.10
Spread: 0.30 (0.628%)
Market Cap: £190.10m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Dividend Policy Update

11 May 2022 07:00

RNS Number : 0247L
CLS Holdings PLC
11 May 2022
 

 

Release date: 11 May 2022

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS" or the "Group")

Updated Dividend Policy, Proposed Tender Offer and Trading Update

 

CLS, a leading FTSE250 office space specialist with a £2.3 billion portfolio in the UK, Germany and France, today announces an updated dividend policy, a proposed tender offer following the publication of the Group's half yearly financial results on 10 August 2022 and a trading update.

 

Updated Dividend Policy

Following the conversion of its UK business to a REIT, CLS has updated its dividend policy for the 2022 financial year onwards. The company will maintain a progressive dividend policy, with a dividend cover of 1.2 to 1.6 times EPRA earnings (previously 1.5 to 2.0 times). It is expected that FY2022 dividend cover will be around the middle of the new range.

 

Proposed Tender Offer

CLS remains committed to its strategy and business model to drive long-term value including its planned 2022 disposals, which to date have been at or above valuations. Nevertheless, the Board of CLS believes the share price discount to its net tangible assets ("NTA") is unjustified and believes that it is in the best interests of all shareholders to take steps to reduce this discount. 

 

Subject to the completion of a number of property sales by the end of the first half of 2022, and the significant share price discount to NTA persisting, CLS intends to undertake a tender offer of its ordinary shares, the terms of which will be announced following the publication of the Group's half yearly financial results on 10 August 2022. The quantum of any tender offer will be scaled to ensure the Group's loan-to-value is still within an acceptable level by the year-end.

 

Trading Update

CLS continues to trade in line with market expectations.

 

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"I am pleased to announce an enhancement to our dividend policy following the conversion of our UK business to a REIT, which will be applied to all future dividends until further notice. 

 

"The Board is clear that the current share price discount to NTA is unjustified given that we are in the process of disposing of a number of properties at or above 31 December 2021 valuations and the quality of our portfolio is proving resilient in a challenging macro environment. Consequently, CLS intends to undertake a tender offer following the 2022 half yearly financial results."

 

This announcement contains inside information.

-ends-

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Richard CrawleyJamie Richards+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)Alex Simmons

Hastings Tarrant

+44 (0)20 3047 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUQGAUPPPPU
Date   Source Headline
16th Dec 20164:40 pmRNSSecond Price Monitoring Extn
16th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 201610:57 amRNSDirector/PDMR Shareholding
30th Nov 201610:24 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSTrading Statement
3rd Nov 201611:46 amRNSDirector/PDMR Shareholding
24th Oct 20164:21 pmRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSDisposals
11th Oct 201610:26 amRNSDirector/PDMR Shareholding
28th Sep 20169:29 amRNSDirector/PDMR Shareholding
27th Sep 20165:16 pmRNSDirector/PDMR Shareholding
22nd Sep 20164:30 pmRNSCompletion of Tender Offer and Total Voting Rights
13th Sep 20163:31 pmRNSResult of Tender Offer
7th Sep 20167:00 amRNSCompletion of Düsseldorf acquisition
26th Aug 20164:48 pmRNSTender Offer
17th Aug 20167:00 amRNSHalf-year Report
11th Jul 20167:00 amRNSAcquisitions
4th Jul 20164:57 pmRNSTR-1: Notification of Major Interest in Shares
28th Jun 20165:07 pmRNSDirector/PDMR Shareholding
27th Jun 20165:27 pmRNSDirector/PDMR Shareholding
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20165:48 pmRNSCorrection - Transaction in Own Shares & TVR
1st Jun 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
31st May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
27th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
26th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
25th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
24th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
20th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
18th May 20163:26 pmRNSDirectors' Details
18th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
17th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
16th May 20165:46 pmRNSCorrection: Director/PDMR Shareholding
16th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
12th May 20167:00 amRNSAnnouncement of Share Buy-Back Programme
11th May 20162:52 pmRNSDirector/PDMR Shareholding
10th May 20164:55 pmRNSDirector/PDMR Shareholding
10th May 20164:10 pmRNSDirector/PDMR Shareholding
3rd May 20164:40 pmRNSSecond Price Monitoring Extn
3rd May 20164:35 pmRNSPrice Monitoring Extension
29th Apr 20164:44 pmRNSCompletion of Tender Offer and Total Voting Rights
28th Apr 20163:44 pmRNSCorrection: Holding(s) in Company
28th Apr 20163:13 pmRNSHolding(s) in Company
28th Apr 20163:01 pmRNSDirector/PDMR Shareholding
28th Apr 20162:57 pmRNSDirector/PDMR Shareholding
20th Apr 20165:01 pmRNSResult of Tender Offer
20th Apr 20161:11 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.